Deleted Tweet from , -D.C.
Deleted Tweet from U.S. FDA
We updated guidance on the conduct of clinical trials of medical products during the #COVID19 public health emergency. The guidance has a new Q&A on an investigator’s responsibility to review all investigational new drug application safety reports. https://t.co/wEU55kcw4m
It looks like this tweet was replaced by the next tweet from @US_FDA.